FDA expands approval of Mavyret for treatment of HCV and cirrhosis
Mavyret marks the first eight-week treatment approved for patients with HCV genotypes 1-6 both without cirrhosis and with…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Sep 19
Mavyret marks the first eight-week treatment approved for patients with HCV genotypes 1-6 both without cirrhosis and with…
26 Sep 19
Eko will use the funding to advance research and development and commercialisation of its machine learning platform for…
26 Sep 19
New MEGADYNE MEGA SOFT Universal Plus is a versatile and easy to use patient return electrode, designed to…
25 Sep 19
Pfizer and Flatiron Health have expanded collaboration to jointly work on integrating real-world evidence for breast cancer medicines
23 Sep 19
The test detects the four different species of Babesia parasites capable of causing disease in humans employing new…
23 Sep 19
Zimmer Biomet Dental has rolled out iTero Element scanners and services in selected countries in Europe and is…
19 Sep 19
Lupus nephritis is an autoimmune disease condition of systemic lupus erythematosus (SLE), where the patient’s own immune system…
17 Sep 19
The integration of technologies enables people with diabetes and their caregivers to track the insulin dosing data and…
16 Sep 19
cobas pro integrated solutions is designed to improve productivity, enhance reliability in the lab and time taken for…
13 Sep 19
Nucala is the only targeted biologic in the US to receive FDA approval for treating eosinophilic asthma in…